Principle Investigator:
Colleen McDonough, MD
“ANHL1131; Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients” Sponsor: Children’s Oncology Group
“AEWS1221; Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma” Sponsor: National Cancer Institute (NCI)